Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection
Author(s) -
Carolyn D. Alonso,
Ciarán P. Kelly,
Kevin W. Garey,
Anne J Gonzales-Luna,
David N. Williams,
Kaitlyn Daugherty,
Christine Cuddemi,
Javier Villafuerte-Gálvez,
Nicole White,
Xinhua Chen,
Hua Xu,
Rebecca Sprague,
Caitlin Barrett,
Mark A. Miller,
Agnès Foussadier,
Aude Lantz,
Alice Banz,
Nira R. Pollock
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab826
Subject(s) - medicine , interquartile range , clostridioides , gastroenterology , toxin , feces , diarrhea , clostridium difficile toxin a , clostridium difficile , antibiotics , microbiology and biotechnology , biology
Stool toxin concentrations may impact Clostridioides difficile infection (CDI) severity and outcomes. We correlated fecal C difficile toxin concentrations, measured by an ultrasensitive and quantitative assay, with CDI baseline severity, attributable outcomes, and recurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom